| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1196/ANNALS.1375.059 |
| P698 | PubMed publication ID | 17130583 |
| P50 | author | Camillo Ricordi | Q37383548 |
| Antonello Pileggi | Q37387749 | ||
| Lorenzo Cobianchi | Q56995754 | ||
| Luca Inverardi | Q114419100 | ||
| P2860 | cites work | The unique cytoarchitecture of human pancreatic islets has implications for islet cell function | Q24541464 |
| Notch signaling controls multiple steps of pancreatic differentiation | Q24569636 | ||
| Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation | Q29614736 | ||
| Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy | Q30853783 | ||
| Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets. | Q31112565 | ||
| Targeted bone marrow radioablation with 153Samarium-lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness | Q33199557 | ||
| A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations | Q33216707 | ||
| Sirolimus-induced ulceration of the small bowel in islet transplant recipients: report of two cases | Q33368841 | ||
| Use of oxygenated perfluorocarbon toward making every pancreas count | Q35033645 | ||
| Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center | Q35668814 | ||
| Clinical islet transplantation: advances and immunological challenges | Q35730793 | ||
| Delivery of proteins and peptides into live cells by means of protein transduction domains: potential application to organ and cell transplantation | Q35808052 | ||
| Requirements for success in clinical islet transplantation | Q36136630 | ||
| New sources of pancreatic beta-cells | Q36186494 | ||
| Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. | Q36417432 | ||
| Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device | Q38453175 | ||
| Insulin independence after living-donor distal pancreatectomy and islet allotransplantation | Q40423359 | ||
| Pancreatic beta-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs | Q40436881 | ||
| Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways. | Q40508923 | ||
| Variables in organ donors that affect the recovery of human islets of Langerhans | Q40982542 | ||
| Underutilization of pancreas donors. | Q42597997 | ||
| Aggressive pharmacologic donor management results in more transplanted organs | Q42695418 | ||
| Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene | Q43618098 | ||
| Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia | Q43729184 | ||
| Efficient transduction of pancreatic islets by feline immunodeficiency virus vectors1. | Q44102776 | ||
| Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets | Q44221067 | ||
| 17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality | Q44228647 | ||
| Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition | Q44256450 | ||
| Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center | Q44260931 | ||
| Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution | Q44469243 | ||
| Insulin independence following isolated islet transplantation and single islet infusions | Q44471640 | ||
| Pancreatic islet transplantation: the radiographic approach | Q44514953 | ||
| Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells | Q44517194 | ||
| Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation | Q44662213 | ||
| Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? | Q44711155 | ||
| Adenoviral gene transfer of erythropoietin confers cytoprotection to isolated pancreatic islets. | Q44728965 | ||
| Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody | Q44763448 | ||
| Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method | Q44981282 | ||
| Enhanced isolated pancreatic islet recovery and functionality in rats by 17beta-estradiol treatment of brain death donors | Q45010690 | ||
| Improvement in islet yield from obese donors for human islet transplants | Q45072975 | ||
| Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture | Q45153742 | ||
| Alterations of the female reproductive system in recipients of islet grafts | Q45183364 | ||
| Rescue purification maximizes the use of human islet preparations for transplantation | Q45214551 | ||
| The portal immunosuppressive storm: relevance to islet transplantation? | Q45234964 | ||
| Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes | Q45267369 | ||
| Cytoprotection of pancreatic islets before and early after transplantation using gene therapy | Q45883293 | ||
| Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience | Q46582092 | ||
| Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus | Q46652782 | ||
| Quality of life after islet transplantation | Q46903634 | ||
| Integrin signaling via RGD peptides and anti-beta1 antibodies confers resistance to apoptosis in islets of Langerhans | Q46917034 | ||
| Modified two-layer preservation method (M-Kyoto/PFC) improves islet yields in islet isolation. | Q46936583 | ||
| Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates | Q46954587 | ||
| Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways | Q46963324 | ||
| Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. | Q47622122 | ||
| The use of non-heart-beating donors for isolated pancreatic islet transplantation | Q48287728 | ||
| Multi-lot analysis of custom collagenase enzyme blend in human islet isolations | Q48690351 | ||
| Health-related quality of life after pancreatic islet transplantation: a longitudinal study. | Q50964521 | ||
| Logistics and transplant coordination activity in the GRAGIL Swiss-French multicenter network of islet transplantation. | Q53273721 | ||
| A functional CD40 receptor is expressed in pancreatic beta cells. | Q54682415 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 383-398 | |
| P577 | publication date | 2006-10-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Overcoming the challenges now limiting islet transplantation: a sequential, integrated approach | |
| P478 | volume | 1079 |
| Q34254821 | A calpain inhibitor enhances the survival of Schwann cells in vitro and after transplantation into the injured spinal cord |
| Q30450509 | Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection |
| Q45876360 | Alpha-1 antitrypsin treatment of spontaneously diabetic nonobese diabetic mice receiving islet allografts |
| Q41968550 | Automated, high-throughput assays for evaluation of human pancreatic islet function |
| Q84557008 | Blockade of leukocyte function antigen-1 (LFA-1) in clinical islet transplantation |
| Q91992991 | Direct differentiation of insulin-producing cells from human urine-derived stem cells |
| Q45958462 | Effects of pancreas cold ischemia on islet function and quality. |
| Q46105824 | Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device |
| Q37422976 | Embryonic stem cell transplantation correlates with endogenous neurogenin 3 expression and pancreas regeneration in streptozotocin-injured mice |
| Q34592604 | Glutathione ethyl ester supplementation during pancreatic islet isolation improves viability and transplant outcomes in a murine marginal islet mass model |
| Q37260577 | Hepatic hematoma after islet cell transplantation |
| Q37149186 | Human pancreatic islets and diabetes research |
| Q42161674 | In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine |
| Q51794380 | Ischemic preconditioning improves islet recovery after pancreas cold preservation. |
| Q42716769 | Islet grafting and imaging in a bioengineered intramuscular space |
| Q43155444 | Isolation of viable porcine islets by selective osmotic shock without enzymatic digestion |
| Q34340690 | Mesenchymal stem cells as feeder cells for pancreatic islet transplants |
| Q42555736 | Point: steady progress and current challenges in clinical islet transplantation |
| Q37377813 | Proangiogenic hydrogels within macroporous scaffolds enhance islet engraftment in an extrahepatic site |
| Q33548278 | Prolactin supplementation to culture medium improves beta-cell survival. |
| Q46468023 | Quantifying Insulin Therapy Requirements to Preserve Islet Graft Function Following Islet Transplantation |
| Q46676115 | Rapamycin impairs beta-cell proliferation in vivo. |
| Q47418206 | Red Ginseng Administration Before Islet Isolation Attenuates Apoptosis and Improves Islet Function and Transplant Outcome in a Syngeneic Mouse Marginal Islet Mass Model |
| Q46421012 | Riboflavin inhibits IL-6 expression and p38 activation in islet cells |
| Q35857021 | Self-assembling glucagon-like peptide 1-mimetic peptide amphiphiles for enhanced activity and proliferation of insulin-secreting cells |
| Q42371850 | Sericin in the isolating solution improves the yield of islets isolated from the pancreas |
| Q58579100 | Tetrahydrocurcumin Enhances Islet Cell Function and Attenuates Apoptosis in Mouse Islets |
| Q46969462 | Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors |
| Q33357060 | Transdisciplinary approach to restore pancreatic islet function. |
Search more.